Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
ConclusionThe recruited population in the ongoing NEURO-TTRansform study has global representation characteristic of contemporary clinical practice.Trial RegistrationClinicalTrials.gov identifier NCT04136184.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Amyloidosis | Australia Health | Brain | Cardiology | Disability | Genetics | Heart | Heart Transplant | Liver | Liver Transplant | Neurology | Study | Transplant Surgery | Transplants | Urology & Nephrology